A pill that increases female sexual libido by boosting Dopamine in the brain has been rejected by the Food and Drug Administration (FDA), The Atlanta Journal-Constitution reports.
Sprout Pharmaceuticals plans to appeal again to the FDA to approve its drug flibanserin. The FDA questioned whether the drug’s benefits outweighed the risks including the side effects fatigue, dizziness and nausea.
Of the 17 appeals for a female equivalent to Viagra the FDA considered last year, 14 were denied, according to government figures obtained by the FDA.
Unlike Viagra, which stimulates erections in men by increasing blood to the genitals, flibanserin acts on chemicals in the female brain.
“Erectile dysfunction is a really easy thing to measure,” says Emory University researcher Kim Wallen.
And Dr. Virginia Sadock, a psychiatrist, says the idea that a single pill can restore female libido oversimplifies the problem.
“A pill just doesn’t take care of it,” says Sadock, who teaches human sexuality at New York University’s School of Medicine.
As many of you know, Dopamine is one of the chemicals our brain produces in response to pleasure stimuli such as drugs, alcohol and sex. Dopamine is the main reason why some women end up in relationships with the wrong men (and vice versa).
Many women who believe they’re in love are actually amped-up on Dopamine. Those passionate relationships usually flame out when the Dopamine fades.
The FDA is aware of the potential problems of a pill that would increase Dopamine in the female brain. Potential problems include increased dependency on addictive drugs and alcohol, hallucinations, euphoria, and depression.
Drug abuse is dependent upon the Dopamine pleasure pathway in our brains. So is sexual attraction.
Some doctors use the male hormone Testosterone (Androgen) to treat women with low libidos. But the side effects of Testosterone (facial hair, acne, deep voice, etc.) outweighs the sexual benefits of the hormone.